We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lack of Stem Cell Regulator Leads to Intestinal Cancer in Mouse Model

By LabMedica International staff writers
Posted on 15 Feb 2015
Print article
Image: PKC-zeta intestinal cancer stem cell regulation (Photo courtesy of Sanford-Burnham Medical Research Institute).
Image: PKC-zeta intestinal cancer stem cell regulation (Photo courtesy of Sanford-Burnham Medical Research Institute).
The interaction of the enzyme protein kinase C-zeta (PKC-zeta) with the enzymes Yap and beta-catenin was found to be a key regulator of intestinal stem cell function and the point where normal cell replacement could give rise to cancerous growth.

PKC-zeta is a member of the PKC family of serine/threonine kinases that are involved in a variety of cellular processes such as proliferation, differentiation, and secretion. Unlike the classical PKC isoenzymes that are calcium-dependent, PKC-zeta exhibits a kinase activity that is independent of calcium and diacylglycerol but not of phosphatidylserine. Furthermore, it is insensitive to typical PKC inhibitors and cannot be activated by phorbol ester.

Investigators at the Sanford-Burnham Medical Research Institute (La Jolla, CA, USA) employed a genetically engineered mouse model for intestinal cancer to study how regulation of homeostasis in intestinal epithelial stem cells could derail and lead to tumor development.

They reported in the February 5, 2015, online edition of the journal Cell Reports that PKC-zeta suppressed intestinal stem cell function by promoting the downregulation of beta-catenin and Yap through direct phosphorylation.

Yap is a transcriptional co-activator and its proliferative and oncogenic activity is driven by its association with the TEAD family of transcription factors, which up-regulate genes that promote cell growth and inhibit apoptosis. Beta-catenin is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. Beta-catenin also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. An increase in beta-catenin production has been noted in those people with basal cell carcinoma and leads to the increase in proliferation of related tumors.

The investigators found that PKC-zeta deficiency with a concomitant rise in Yap and beta-catenin activity resulted in increased stem cell activity in organoid cultures and in vivo, accounting for the increased tumorigenic and regenerative action in the PKC-zeta-deficient mice.

“Accumulating evidence suggests that cancer stem cells are responsible for cancer initiation, progression, metastasis, recurrence, and drug resistance,” said senior author Dr. Jorge Moscat, director of the cell death and survival networks program at the Sanford-Burnham Medical Research Institute. “Our new research provides a better understanding of the signaling cascades that regulate stem cells and is essential for the design of new and more-efficacious therapies for cancer. Our results offer new possibilities for the prevention and treatment of intestinal cancers by blocking the pathways that lead to tumors. They also highlight a new strategy to promote intestinal regeneration after acute or chronic damage, such as that triggered by chemotherapy and radiation.”

Related Links:

Sanford-Burnham Medical Research Institute



Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.